The Cluster 1 Type VI Secretion System Is a Major Virulence Determinant in Burkholderia pseudomallei

被引:228
|
作者
Burtnick, Mary N. [2 ]
Brett, Paul J. [2 ]
Harding, Sarah V. [3 ]
Ngugi, Sarah A. [3 ]
Ribot, Wilson J. [1 ]
Chantratita, Narisara [4 ,5 ]
Scorpio, Angelo [6 ]
Milne, Timothy S. [3 ]
Dean, Rachel E. [3 ]
Fritz, David L. [1 ]
Peacock, Sharon J. [7 ]
Prior, Joanne L. [3 ]
Atkins, Timothy P. [3 ]
DeShazer, David [1 ]
机构
[1] USA, Bacteriol Div, MRIID, Frederick, MD 21702 USA
[2] Univ S Alabama, Dept Microbiol & Immunol, Mobile, AL 36688 USA
[3] Def Sci & Technol Lab, Dept Biomed Sci, Salisbury SP4 0JQ, Wilts, England
[4] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand
[5] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand
[6] Natl Biodef Anal & Countermeasures Ctr, Frederick, MD 21702 USA
[7] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England
关键词
RAW-264.7 MURINE MACROPHAGES; MALLEI; MELIOIDOSIS; CELLS; MUTANTS; IDENTIFICATION; MUTAGENESIS; EXPRESSION; GLANDERS; BACTERIA;
D O I
10.1128/IAI.01218-10
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Burkholderia pseudomallei K96243 genome encodes six type VI secretion systems (T6SSs), but little is known about the role of these systems in the biology of B. pseudomallei. In this study, we purified recombinant Hcp proteins from each T6SS and tested them as vaccine candidates in the BALB/c mouse model of melioidosis. Recombinant Hcp2 protected 80% of mice against a lethal challenge with K96243, while recombinant Hcp1, Hcp3, and Hcp6 protected 50% of mice against challenge. Hcp6 was the only Hcp constitutively produced by B. pseudomallei in vitro; however, it was not exported to the extracellular milieu. Hcp1, on the other hand, was produced and exported in vitro when the VirAG two-component regulatory system was overexpressed in trans. We also constructed six hcp deletion mutants (Delta hcp1 through Delta hcp6) and tested them for virulence in the Syrian hamster model of infection. The 50% lethal doses (LD(50)s) for the Delta hcp2 through Delta hcp6 mutants were indistinguishable from K96243 (< 10 bacteria), but the LD50 for the Delta hcp1 mutant was > 10(3) bacteria. The hcp1 deletion mutant also exhibited a growth defect in RAW 264.7 macrophages and was unable to form multinucleated giant cells in this cell line. Unlike K96243, the Delta hcp1 mutant was only weakly cytotoxic to RAW 264.7 macrophages 18 h after infection. The results suggest that the cluster 1 T6SS is essential for virulence and plays an important role in the intracellular lifestyle of B. pseudomallei.
引用
收藏
页码:1512 / 1525
页数:14
相关论文
共 50 条
  • [41] Chromobacterium pathogenicity island 1 type III secretion system is a major virulence determinant for Chromobacterium violaceum-induced cell death in hepatocytes
    Miki, Tsuyoshi
    Iguchi, Mirei
    Akiba, Kinari
    Hosono, Masato
    Sobue, Tomoyoshi
    Danbara, Hirofumi
    Okada, Nobuhiko
    MOLECULAR MICROBIOLOGY, 2010, 77 (04) : 855 - 872
  • [42] Type III secretion:: a virulence factor delivery system essential for the pathogenicity of Burkholderia mallei
    Urich, RL
    DeShazer, D
    INFECTION AND IMMUNITY, 2004, 72 (02) : 1150 - 1154
  • [43] TssB is essential for virulence and required for Type VI secretion system in Ralstonia solanacearum
    Zhang, Liqing
    Xu, Jingsheng
    Xu, Jin
    Zhang, Hao
    He, Liyuan
    Feng, Jie
    MICROBIAL PATHOGENESIS, 2014, 74 : 1 - 7
  • [44] Identification of a novel two-partner secretion system from Burkholderia pseudomallei
    N. F. Brown
    C.-A. Logue
    J. A. Boddey
    R. Scott
    R. G. Hirst
    I. R. Beacham
    Molecular Genetics and Genomics, 2004, 272 : 204 - 215
  • [45] Identification of a novel two-partner secretion system from Burkholderia pseudomallei
    Brown, NF
    Logue, CA
    Boddey, JA
    Scott, R
    Hirst, RG
    Beacham, IR
    MOLECULAR GENETICS AND GENOMICS, 2004, 272 (02) : 204 - 215
  • [46] Development and evaluation of a real-time PCR assay targeting the type III secretion system of Burkholderia pseudomallei
    Novak, RT
    Glass, MB
    Gee, JE
    Gal, D
    Mayo, MJ
    Currie, BJ
    Wilkins, PP
    JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (01) : 85 - 90
  • [47] Quantitative Proteomic Analysis of Burkholderia pseudomallei Bsa Type III Secretion System Effectors Using Hypersecreting Mutants
    Vander Broek, Charles W.
    Chalmers, Kevin J.
    Stevens, Mark P.
    Stevens, Joanne M.
    MOLECULAR & CELLULAR PROTEOMICS, 2015, 14 (04) : 905 - 916
  • [48] The Burkholderia pseudomallei Type III Secretion System and BopA Are Required for Evasion of LC3-Associated Phagocytosis
    Gong, Lan
    Cullinane, Meabh
    Treerat, Puthayalai
    Ramm, Georg
    Prescott, Mark
    Adler, Ben
    Boyce, John D.
    Devenish, Rodney J.
    PLOS ONE, 2011, 6 (03):
  • [49] Expression, purification, crystallization and preliminary crystallographic analysis of BipD, a component of the Burkholderia pseudomallei type III secretion system
    Roversi, Pietro
    Johnson, Steven
    Field, Terry
    Deane, Janet E.
    Galyov, Edouard E.
    Lea, Susan M.
    ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS, 2006, 62 : 861 - 864
  • [50] Presence of type III secretion genes in Burkholderia pseudomallei correlates with Ara- phenotypes
    Winstanley, C
    Hart, CA
    JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (02) : 883 - 885